FDA Clearance Tracker · K160664
Aqueduct 100 Cervical Dilator
Last checked: Nov 19, 2026Latest source record: Aug 1, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Aug 1, 2016
Substantially Equivalent
Time to decision
145 days
Received Mar 9, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Abbreviated
Device class
Class II
The decision
- FDA number
- K160664
- Device name
- Aqueduct 100 Cervical Dilator
- Applicant
- Gtimd, LLC
- Applicant location
- Amherst, NH
- Received
- Mar 9, 2016
- Decided
- Aug 1, 2016
- Decision
- Substantially Equivalent
- Submission type
- Abbreviated
Device type
- Device class
- Class II
- Regulation
- 21 CFR 884.4260
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PON (Catheter, Balloon, Dilation Of Cervical Canal).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K160664
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Gtimd, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202433 · Decided Oct 15, 2021 · 416 days after receipt
Device type: Catheter, Balloon, Dilation Of Cervical Canal (PON) · Obstetrics & Gynecology
K202427 · Decided Nov 6, 2020 · 73 days after receipt
Device type: Catheter, Balloon, Dilation Of Cervical Canal (PON) · Obstetrics & Gynecology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.